Arcutis Biotherapeutics Inc (NASDAQ: ARQT) established initial surge of 3.42% at $29.04, as the Stock market unbolted on Wednesday, before settling in for the price of $28.08 at the close. Taking a more long-term approach, ARQT posted a 52-week range of $11.13-$31.77.
The Healthcare sector firm’s twelve-monthly sales growth has been -0.98% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -0.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 81.92%. This publicly-traded company’s shares outstanding now amounts to $120.29 million, simultaneously with a float of $107.63 million. The organization now has a market capitalization sitting at $3.56 billion. At the time of writing, stock’s 50-day Moving Average stood at $26.99, while the 200-day Moving Average is $18.41.
Arcutis Biotherapeutics Inc (ARQT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Arcutis Biotherapeutics Inc industry. Arcutis Biotherapeutics Inc’s current insider ownership accounts for 12.14%, in contrast to 96.72% institutional ownership. Preceding that transaction, on Dec 15 ’25, Company’s insider sold 11,500 for 28.94, making the whole transaction’s value amount to 332,851. This particular insider is now the holder of 98,307 in total.
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Trading Performance Indicators
Let’s observe the current performance indicators for Arcutis Biotherapeutics Inc (ARQT). It’s Quick Ratio in the last reported quarter now stands at 3.28. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.19.
In the same vein, ARQT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.35, a figure that is expected to reach 0.07 in the next quarter, and analysts are predicting that it will be 0.46 at the market close of one year from today.
Technical Analysis of Arcutis Biotherapeutics Inc (ARQT)
Now, what If we examine the latest scores posted by [Arcutis Biotherapeutics Inc, ARQT]. During the last 5-days, its volume was lower the volume of 2.15 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 37.38% While, its Average True Range was 51.78.
Raw Stochastic average of Arcutis Biotherapeutics Inc (ARQT) in the period of the previous 100 days is set at 84.61%, which indicates a major rise in contrast to 55.06% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.02 that was lower than 1.07 volatility it exhibited in the past 100-days period.
